Site içinde arama yapın | La Lingua Nostra

ROHIT GAURYA bir dosya eklendi Health
2026-03-31 10:29:12 -

GVHD Treatment Market to Reach USD 2.1 Billion by 2031 | CAGR 8.5%
According to a newly published market research report by 24LifeSciences, global Graft Versus Host Disease (GVHD) Treatment market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252031. Graft versus Host Disease, a serious complication following stem cell or bone...

0 Yorumlar 0 hisse senetleri 218 Views 0 önizleme

Please log in to like, share and comment!
Komal Galande bir dosya eklendi Health
2026-04-22 05:46:48 -

Is the EPO Drugs Market Expanding with Advancements in Anemia Treatment?
Global Demand Outlook for Executive Summary Erythropoietin (EPO) Drugs Market Size and Share CAGR Value Global Erythropoietin (EPO) Drugs Market report is a highly visual business report where the key market research findings have been organized, analyzed, and summarized neatly. This report can be communicated more effectively with a team, stakeholders, and customers. With devotion,...

0 Yorumlar 0 hisse senetleri 9 Views 0 önizleme

Please log in to like, share and comment!
ROHIT GAURYA bir dosya eklendi Health
2026-04-06 12:37:37 -

Rare Hemophilia Factors Market to Reach USD 247 Million by 2031 | CAGR 3.1%
According to a newly published market research report by 24LifeSciences, global rare hemophilia factors market was valued at USD 200 million in 2024 and is projected to reach USD 247 million by 2031, growing at a compound annual growth rate (CAGR) of 3.1% during the forecast period 2025-2031. Rare hemophilia factors represent specialized blood-clotting proteins essential for treating...

0 Yorumlar 0 hisse senetleri 176 Views 0 önizleme

Please log in to like, share and comment!